Stay updated on Talquetamab Pre-Approval Access in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Talquetamab Pre-Approval Access in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talquetamab Pre-Approval Access in Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-12T20:21:19.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Version update from v3.4.1 to v3.4.2 with no visible changes to the study record or page content.
    Difference
    0.1%
    Check dated 2026-02-12T01:40:24.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1 and no longer shows Revision: v3.4.0, which is an internal versioning update that does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:36:15.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The changes are limited to UI/text updates and versioning, including a new 'Show glossary' option and minor wording/capitalization adjustments to labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T21:32:23.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.3 to v3.3.4, which appears to be a backend or formatting change and does not modify study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:47:02.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer changes include the addition of Revision: v3.3.3 and the removal of the HHS Vulnerability Disclosure link and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T20:56:08.000Z thumbnail image

Stay in the know with updates to Talquetamab Pre-Approval Access in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talquetamab Pre-Approval Access in Myeloma Clinical Trial page.